Long COVID rehab study halted early – what we know
NCT ID NCT05398692
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether a supervised exercise and pulmonary rehabilitation program could help people with Long COVID feel better and move more easily. Researchers measured changes in aerobic capacity, fatigue, and quality of life in 21 adults who had COVID at least 12 weeks earlier. The study was terminated early, so the findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- On-site exercise and pulmonary rehabilitation program
- What this could lead to
- If successful, this program could offer a structured way to improve fitness and reduce fatigue for people with Long COVID.
- What could go wrong
- The study was terminated early with only 21 participants, so results are limited and may not apply broadly. Exercise may worsen symptoms like post-exertional malaise in some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California, 90509, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?